November 2011 Volume 42 Number 5
A Spicamycin Derivative (KRN5500) Provides Neuropathic Pain Relief in Patients With Advanced Cancer: A Placebo-Controlled, Proof-of-Concept Trial
Sharon M. Weinstein, MD, Amy P. Abernethy, MD, Susan E. Spruill, PStat, MS, Isadore M. Pike, MD, Andrea True Kelly, PhD, and Linda G. Jett, MSN
This article has been published online prior to it being assigned to a volume and issue of the journal. It is available to order and would be printed with a DOI (doi:10.1016/j.jpainsymman.2011.05.003) as its reference. The DOI can and should be used in place of the absent volume, issue, and page numbers to cite this article.